Search bioRxivSearch

Biology subjects

Sadasivan Nair, S.

Publications and source records attributed to Sadasivan Nair, S..

2 recordsLinked to original sources

Can proteomics of snake venoms help drug discovery? A study on the venom of spectacled cobra (Naja naja) from the Western Ghats

Venom proteome profiling of Naja naja from the Western Ghats region in Kerala was achieved through SDS-PAGE and RP-HPLC followed by Q-TOF LC-MS/MS analysis, incorporating PEAKS and Novor assisted de novo sequencing methodologies. A total of 115 proteins distributed across 17 different enzymatic and non-enzymatic venom protein families were identified through conventional and 39 peptides through homology-driven proteomics approaches. Fourteen peptides derived through de novo complements the Mascot data indicating the importance of homology-driven approaches in improving protein sequence information. Among the protein families identified, glutathione peroxidase and endonuclease were reported for the first time in the Indian cobra venom. Immunological cross-reactivity assessed using Indian polyvalent antivenoms suggested that VINS showed better EC50 (2.48 g/mL) value than that of PSAV (6.04 g/mL) and Virchow (6.03 g/mL) antivenoms. Western blotting experiments indicated that all the antivenoms elicited poor binding specificities, especially towards low molecular mass proteins. Second-generation antivenomics studies revealed that VINS antivenom was less efficient to detect many low molecular mass proteins such as three-finger toxins and Kunitz-type serine protease Inhibitors. Taken together, the present study enabled a large-scale characterization of the venom proteome of Naja naja from the Western Ghats and emphasized the need for developing more efficient antivenoms. HighlightsO_LIProteomics of cobra venom resulted in the identification of 115 proteins representing 17 snake venom protein families. C_LIO_LIDe novo approaches exclusively yielded 39 peptides harbouring multiple amino acid mutations. C_LIO_LIGlutathione peroxidase and endonuclease were identified for the first time in Indian cobra venom. C_LIO_LIIndian polyvalent antivenoms showed varying cross-reactivity towards cobra venom. C_LIO_LIVINS antivenom was less efficient to detect many low molecular mass proteins (< 20 kDa). C_LI

pharmacology and toxicology

Evaluating the Immunological cross-reactivity of Indian polyvalent antivenoms towards the venom of Hypnale hypnale (hump-nosed pit viper) from the Western Ghats

Hypnale hypnale (hump-nosed pit viper) is a venomous pit viper species found in the Western Ghats of India and Sri Lanka. Due to the severe life-threatening envenomation effects induced by its venom components, Hypnale hypnale has been classified under category 1 of medically important snake species by the World Health Organization. Since there are no specific antivenoms available to combat its envenomation in India, the only option available is to administer Indian polyvalent antivenoms. However, the cross-neutralization potential of the commercially available polyvalent antivenoms on Indian Hypnale hypnale venom has not been explored so far. In the current study, in vitro immunological cross-reactivity of Hypnale hypnale venom towards various Indian polyvalent antivenoms were assessed using end point titration ELISA and Western blotting. A three to four-fold increase in EC50 values were obtained for Hypnale hypnale venom towards all the antivenoms tested. Observation of minimal binding specificities towards low and high molecular mass venom proteins are suggestive of the fact that commercially available polyvalent antivenoms failed to detect and bind to the antigenic epitopes of considerable number of proteins present in Hypnale hypnale venom. This highlights the importance of including Hypnale hypnale venom in the immunization mixture while raising antivenoms.

pharmacology and toxicology